Viewing Protocol Section

Home

Certify Doc

Genes

Clinical Trials

CompTox

DrugMatrix

Open Targets

Products

Support

Bugs

eRecord

Main Search All Studies All Organizations Report Bug

Viewing Protocol Section

Thank You for evaluating our software.

Clinical Trials

To give you an idea of how we make custom software. We have taken all of the Clinical Trials Information from our Federal Government(https://clinicaltrials.gov/).

The JSON File Structure of the files is as follows: Full Study -> Study => Sections => Modules. You are currently viewing a Protocol Section and its Modules.

We give the table structure here to give you an idea of what you are looking at. We put the explanation to the left and the data to the right.

A Protocol Section has the following Modules.

1. Identification Module

2. Status Module

3. Sponsor Collaborators Module

4. Oversight Module

5. Description Module

6. Conditions Module

7. Design Module

8. Arms Interventions Module

9. Outcomes Module

10. Eligibility Module

11. Contacts Locations Module

12. References Module

13. IPD Sharing Statement Module

Viewing Protocol Section

Study NCT06469944

Ignite Creation Date: 2024-07-17 @ 11:13 AM

Last Modification Date: 2024-10-26 @ 3:32 PM

Study NCT ID: NCT06469944

Protocol Section: NCT06469944

Start Identification Module Data

Expand Identification Module Data

Brief Title: Substudy 06C A Study of Sacituzumab Tirumotecan MK-2870 With Pembrolizumab MK-3475 and Chemotherapy in Participants With First-Line Locally Advanced UnresectableMetastatic Gastroesophageal Adenocarcinoma MK-3475-06CKEYMAKER-U06

Official Title: A Phase 12 Open-Label Umbrella Platform Design Study of MK-2870 With Pembrolizumab MK-3475 and Chemotherapy in Participants With 1L Locally Advanced UnresectableMetastatic Gastroesophageal Adenocarcinoma Gastric Adenocarcinoma Gastroesophageal Junction Adenocarcinoma and Esophageal Adenocarcinoma Substudy 06C

Acronym: None

Organization: Merck Sharp Dohme LLC

Organization Class: INDUSTRY

Organization Study ID: 3475-06C

Secondary IDs

Secondary ID	Type	Domain	Link

MK-3475-06C	OTHER	None	None
KEYMAKER-06C	OTHER	None	None
2023-509307-33	REGISTRY	None	None
U1111-1299-8084	OTHER	None	None

Start Status Module Data

Status Verified Date: 2024-10

Overall Status: RECRUITING

Study First Submit Date:

Study First Submit QC Date:

Last Update Submit Date:

Status:

Start Sponsor Collaborators Module Data

Investigator:

Lead Sponsor: Merck Sharp Dohme LLC

Lead Sponsor Class: INDUSTRY

Lead Sponsor: Merck Sharp Dohme LLC

Start Oversight Module Data

Description Module:

Study Last Update Post Date Type(Status Module):

Attachment: Upload